Kumar, B. (2018) “RESVERATROL INHIBITS EXPRESSION OF CANCER-SPECIFIC PENTOSE PHOSPHATE PATHWAY ENZYME TKTL1”, Asian Journal of Pharmaceutical and Clinical Research, 11(6), pp. 332–335. doi: 10.22159/ajpcr.2018.v11i6.25021.